Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy

Glioblastoma multiforme (GBM) is a common, usually lethal disease with a median survival of only ~15 months. It has proven resistant in clinical trials to chemotherapeutic agents such as paclitaxel that are highly effective in vitro, presumably because of impaired drug delivery across the tumor'...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Brian C., Kao, Gary D., Mahmud, Abdullah, Harada, Takamasa, Swift, Joe, Chapman, Christina, Xu, Xiangsheng, Discher, Dennis E., Dorsey, Jay F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702208/
https://www.ncbi.nlm.nih.gov/pubmed/23296073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702208/
https://www.ncbi.nlm.nih.gov/pubmed/23296073

Ejemplares similares